Latest Articles
Back-to-school shopping? Teachers and students can get 20% off with Target Circle - Mashable
Back-to-school shopping? Teachers and students can get 20% off with Target Circle Mashable
Published: April 25, 2026, 9 a.m.
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha - Targeting ADC at AACR Annual Meeting 2026 - riauone.com
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha - Targeting ADC at AACR Annual Meeting 2026 riauone.com
Published: April 24, 2026, 4:01 a.m.
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026 - The Manila Times
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026 The Manila Times
Published: April 21, 2026, 9:40 p.m.
SGO 2026: Ovarian OS Gains and New Endometrial Targets - Medscape
SGO 2026: Ovarian OS Gains and New Endometrial Targets Medscape
Published: April 17, 2026, 6:56 p.m.
NHS women’s health strategy targets ‘medical gaslighting’ - Pharmacy Business
NHS women’s health strategy targets ‘medical gaslighting’ Pharmacy Business
Published: April 17, 2026, 8:48 a.m.
ABSI: ABS-201 targets AGA and endometriosis with AI-designed antibodies, aiming for major clinical milestones - TradingView — Track All Markets
ABSI: ABS-201 targets AGA and endometriosis with AI-designed antibodies, aiming for major clinical milestones TradingView — Track All Markets
Published: April 16, 2026, 8:21 p.m.
Advancing ABS-201 in Underserved Hair Loss and Endometriosis Markets Supports Buy Rating and $9 Target - TipRanks
Advancing ABS-201 in Underserved Hair Loss and Endometriosis Markets Supports Buy Rating and $9 Target TipRanks
Published: April 15, 2026, 9:42 p.m.
Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy - TipRanks
Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy TipRanks
Published: April 15, 2026, 1:38 p.m.
LRP1 as a potential diagnostic and immunomodulatory target in endometriosis: evidence from multi-omics and single-cell analyses - Frontiers
LRP1 as a potential diagnostic and immunomodulatory target in endometriosis: evidence from multi-omics and single-cell analyses Frontiers
Published: April 15, 2026, 10:36 a.m.
Dr. Pothuri Discusses Emerging ADCs in HER2-Expressing Endometrial Cancer - Targeted Oncology
Dr. Pothuri Discusses Emerging ADCs in HER2-Expressing Endometrial Cancer Targeted Oncology
Published: April 14, 2026, 5:46 p.m.
Link copied to clipboard!